Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 04-Sep-24 8:20 PM View:  | Regenxbio Inc. (RGNX) | 03-Sep-24 | Option Exercise | 10,000 | $3.76 | $37,600.00 | 89% 11.29K to 21.29K | |
| 04-Sep-24 8:20 PM View: | Regenxbio Inc. (RGNX) | 03-Sep-24 | Planned Option Sale | 10,000 | $11.56 | $115,588.00 | (47%) 21.29K to 11.29K | |
| 05-Aug-24 6:39 PM View: | Regenxbio Inc. (RGNX) | 01-Aug-24 | Option Exercise | 10,100 | $3.85 | $38,874.00 | 89% 11.29K to 21.39K | |
| 05-Aug-24 6:39 PM View: | Regenxbio Inc. (RGNX) | 01-Aug-24 | Planned Option Sale | 10,100 | $13.51 | $136,454.00 | (47%) 21.39K to 11.29K | |
| 30-Jul-24 5:01 PM View: | Regenxbio Inc. (RGNX) | 29-Jul-24 | Option Exercise | 11,000 | $12.74 | $140,140.00 | 97% 11.29K to 22.29K | |
| 30-Jul-24 5:01 PM View: | Regenxbio Inc. (RGNX) | 29-Jul-24 | Planned Option Sale | 11,000 | $15.05 | $165,495.00 | (49%) 22.29K to 11.29K | |
| 03-Jul-24 7:55 AM View: | Regenxbio Inc. (RGNX) | 01-Jul-24 | Option Exercise | 10,000 | $3.76 | $37,600.00 | 89% 11.29K to 21.29K | |
| 03-Jul-24 7:55 AM View: | Regenxbio Inc. (RGNX) | 01-Jul-24 | Planned Option Sale | 10,000 | $11.27 | $112,691.00 | (47%) 21.29K to 11.29K | |
| 04-Jun-24 4:42 PM View: | Regenxbio Inc. (RGNX) | 31-May-24 | Grant | 4,790 | -- | -- | 74% 6.5K to 11.29K | |
| 06-Jun-23 10:00 PM View: | Regenxbio Inc. (RGNX) | 02-Jun-23 | Grant | 3,486 | -- | -- | 116% 3.01K to 6.5K | |
| 28-Jun-22 4:38 PM View: | Valeant Pharmaceuticals Int... (BHC) | 24-Jun-22 | Grant | 34,387 | -- | -- | 38% 89.33K to 123.72K | |
| 07-Jun-22 4:20 PM View: | Regenxbio Inc. (RGNX) | 03-Jun-22 | Grant | 3,010 | -- | -- | 100% 0 to 3.01K | |
| 03-May-21 4:07 PM View: | Valeant Pharmaceuticals Int... (BHC) | 30-Apr-21 | Grant | 7,645 | -- | -- | 9% 81.68K to 89.33K | |
| 01-May-20 4:15 PM View: | Valeant Pharmaceuticals Int... (BHC) | 01-May-20 | Grant | 11,037 | -- | -- | 16% 70.65K to 81.68K | |
| 03-May-19 4:14 PM View: | Valeant Pharmaceuticals Int... (BHC) | 03-May-19 | Grant | 10,633 | $23.51 | $249,982.00 | 18% 60.01K to 70.65K | (< 1%) |
| 04-May-18 5:54 PM View: | Valeant Pharmaceuticals Int... (BHC) | 03-May-18 | Grant | 14,285 | -- | -- | 31% 46.13K to 60.42K | |
| 05-May-17 5:22 PM View: | Valeant Pharmaceuticals Int... (BHC) | 05-May-17 | Grant | 25,406 | -- | -- | 123% 20.73K to 46.13K | |
| 12-Aug-16 4:37 PM View: | Valeant Pharmaceuticals Int... (BHC) | 11-Aug-16 | Market Purchase | 4,000 | $24.65 | $98,600.00 | 24% 16.73K to 20.73K | (4%) |
| 21-Jun-16 8:01 PM View: | Valeant Pharmaceuticals Int... (BHC) | 17-Jun-16 | Grant | 16,726 | -- | -- | 100% 0 to 16.73K | |
| 25-Feb-15 6:19 PM View: | Rocket Pharmaceuticals, Inc. (RCKT) | 23-Feb-15 | Conversion Duplicate | 1,458,200 | -- | -- | 42% 3.5M to 4.96M | |
| 25-Feb-15 6:19 PM View: | Rocket Pharmaceuticals, Inc. (RCKT) | 23-Feb-15 | Purchase Duplicate | 603,832 | $6.00 | $3,622,990.00 | 12% 4.96M to 5.56M | |
| 01-Aug-12 1:57 PM View: | Human Genome Sciences Inc. (HGSI) | 30-Jul-12 | Disposition | 4,166 | $14.25 | $59,365.50 | (19%) 21.94K to 17.78K | < 1% |
| 01-Aug-12 1:57 PM View: | Human Genome Sciences Inc. (HGSI) | 30-Jul-12 | Disposition (change in control) | 17,776 | $14.25 | $253,308.00 | (100%) 17.78K to 0 | < 1% |
| 11-Jul-12 10:45 AM View: | Human Genome Sciences Inc. (HGSI) | 10-Jul-12 | Grant | 728 | $13.64 | $9,929.92 | 3% 21.21K to 21.94K | 0% |
| 21-May-12 9:41 AM View: | Human Genome Sciences Inc. (HGSI) | 17-May-12 | Grant | 2,500 | -- | -- | 13% 18.71K to 21.21K | |
| 12-Apr-12 10:25 AM View: | Human Genome Sciences Inc. (HGSI) | 10-Apr-12 | Grant | 1,120 | $7.53 | $8,433.60 | 6% 17.59K to 18.71K | < 1% |
| 11-Jan-12 2:57 PM View: | Human Genome Sciences Inc. (HGSI) | 10-Jan-12 | Grant | 1,237 | $8.03 | $9,933.11 | 8% 16.36K to 17.59K | 0% |
| 12-Oct-11 11:22 AM View: | Human Genome Sciences Inc. (HGSI) | 10-Oct-11 | Grant | 746 | $11.13 | $8,302.98 | 5% 15.61K to 16.36K | (< 1%) |
| 11-Jul-11 3:39 PM View: | Human Genome Sciences Inc. (HGSI) | 10-Jul-11 | Grant | 303 | $24.52 | $7,429.56 | 2% 15.31K to 15.61K | 0% |
| 16-May-11 11:32 AM View: | Human Genome Sciences Inc. (HGSI) | 12-May-11 | Grant | 2,500 | -- | -- | 20% 12.81K to 15.31K | |
| 13-Apr-11 3:42 PM View: | Human Genome Sciences Inc. (HGSI) | 10-Apr-11 | Grant | 308 | $28.74 | $8,851.92 | 2% 12.5K to 12.81K | 2% |
| 15-Mar-10 1:30 PM View: | Vanda Pharmaceuticals, Inc. (VNDA) | 12-Mar-10 | Market Sale Duplicate | 200,000 | $11.80 | $2,360,000.00 | (100%) 200.0K to 0 | (11%) |
| 16-Dec-09 12:48 PM View: | Vanda Pharmaceuticals, Inc. (VNDA) | 15-Dec-09 | Market Sale Duplicate | 98,924 | $11.03 | $1,091,130.00 | (33%) 298.92K to 200.0K | (19%) |
| 16-Dec-09 12:48 PM View: | Vanda Pharmaceuticals, Inc. (VNDA) | 14-Dec-09 | Market Sale Duplicate | 130,000 | $11.14 | $1,448,200.00 | (30%) 428.92K to 298.92K | (18%) |
| 10-Dec-09 1:44 PM View: | Vanda Pharmaceuticals, Inc. (VNDA) | 09-Dec-09 | Market Sale | 107,200 | $11.57 | $1,240,300.00 | (20%) 536.12K to 428.92K | (14%) |
| 10-Dec-09 1:44 PM View: | Vanda Pharmaceuticals, Inc. (VNDA) | 08-Dec-09 | Market Sale | 26,376 | $11.30 | $298,049.00 | (5%) 562.5K to 536.12K | (16%) |
| 08-Dec-09 1:31 PM View: | Vanda Pharmaceuticals, Inc. (VNDA) | 07-Dec-09 | Market Sale | 100,000 | $11.57 | $1,157,000.00 | (15%) 662.5K to 562.5K | (14%) |
| 08-Dec-09 1:31 PM View: | Vanda Pharmaceuticals, Inc. (VNDA) | 04-Dec-09 | Market Sale | 100,000 | $11.70 | $1,170,000.00 | (13%) 762.5K to 662.5K | (12%) |
| 15-Oct-09 3:56 PM View: | Vanda Pharmaceuticals, Inc. (VNDA) | 13-Oct-09 | Market Sale Duplicate | 237,500 | $12.65 | $3,004,380.00 | (24%) 1000.0K to 762.5K | (4%) |
| 28-Apr-09 3:16 PM View: | NitroMed Inc. (NTMD) | 24-Apr-09 | Disposition | 11,179 | -- | -- | (< 1%) 1.34M to 1.33M | |
| 28-Apr-09 3:16 PM View: | NitroMed Inc. (NTMD) | 24-Apr-09 | Disposition | 1,332,860 | -- | -- | (100%) 1.33M to 0 | |
| 27-Feb-07 11:05 AM View: | Vanda Pharmaceuticals, Inc. (VNDA) | 23-Feb-07 | Market Sale Duplicate | 384,130 | $26.02 | $9,993,760.00 | (28%) 1.38M to 1000.0K | 48% |
| 23-Feb-07 11:57 AM View: | Vanda Pharmaceuticals, Inc. (VNDA) | 22-Feb-07 | Market Sale Duplicate | 72,600 | $26.82 | $1,947,330.00 | (5%) 1.46M to 1.38M | 50% |
| 22-Feb-07 4:09 PM View: | Vanda Pharmaceuticals, Inc. (VNDA) | 21-Feb-07 | Market Sale | 237,000 | $26.74 | $6,337,380.00 | (14%) 1.69M to 1.46M | 49% |
| 22-Feb-07 4:09 PM View: | Vanda Pharmaceuticals, Inc. (VNDA) | 20-Feb-07 | Market Sale | 200,000 | $27.37 | $5,474,360.00 | (11%) 1.89M to 1.69M | 51% |
| 14-Dec-06 4:12 PM View: | Vanda Pharmaceuticals, Inc. (VNDA) | 12-Dec-06 | Market Sale | 424,150 | $25.18 | $10,680,100.00 | (18%) 2.32M to 1.89M | 46% |
| 13-Dec-06 2:22 PM View: | Vanda Pharmaceuticals, Inc. (VNDA) | 11-Dec-06 | Market Sale Duplicate | 326,325 | $26.40 | $8,614,980.00 | (12%) 2.64M to 2.32M | 49% |
| 29-Nov-06 3:04 PM View: | Vanda Pharmaceuticals, Inc. (VNDA) | 27-Nov-06 | Market Sale Duplicate | 300,000 | $14.18 | $4,254,000.00 | (10%) 2.94M to 2.64M | 5% |
| 27-Nov-06 4:55 PM View: | Vanda Pharmaceuticals, Inc. (VNDA) | 22-Nov-06 | Market Sale Duplicate | 300,000 | $14.12 | $4,236,000.00 | (9%) 3.24M to 2.94M | 4% |
| 22-Nov-06 3:40 PM View: | Vanda Pharmaceuticals, Inc. (VNDA) | 21-Nov-06 | Market Sale | 50,000 | $14.55 | $727,500.00 | (2%) 3.29M to 3.24M | 7% |